uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Change in Accured Expenses (2016 - 2026)

uniQure (QURE) posted quarterly Change in Accured Expenses of $7.2 million for Q2 2026, up 446.69% year-over-year from $1.3 million in Q2 2025, and up 83.84% quarter-over-quarter from $3.9 million in Q1 2026.

Analysis

uniQure (QURE) Change in Accured Expenses (2016 - 2026) Analysis & Trends

uniQure's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $7.2 million for Q2 2026.

  • In Q2 2026, Change in Accured Expenses rose 446.69% year-over-year to $7.2 million; the TTM figure through Jun 2026 stood at $18.8 million (up 610.59% YoY), while the FY2025 annual figure was $4.5 million, up 179.3% from the prior year.
  • Change in Accured Expenses for Q2 2026 stood at $7.2 million, up from $3.9 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $22.6 million in Q3 2025, with the low at -$14.8 million in Q4 2025.
  • The 5-year median for Change in Accured Expenses is $215500.0 (2022), against an average of $441833.3.
  • The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 682.77% in 2024, then jumped 537.32% in 2025.
  • uniQure's Change in Accured Expenses stood at -$248000.0 in 2022, then soared by 373.79% to $679000.0 in 2023, then plunged by 682.77% to -$4.0 million in 2024, then sank by 275.21% to -$14.8 million in 2025, then jumped by 148.27% to $7.2 million in 2026.
  • Business Quant data shows QURE's Change in Accured Expenses at $7.2 million in Q2 2026, $3.9 million in Q1 2026, and -$14.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 7.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.17 Mn
Mar 31, 2026 3.90 Mn
Dec 31, 2025 -14.85 Mn
Sep 30, 2025 22.59 Mn
Jun 30, 2025 -2.07 Mn
Mar 31, 2025 -1.21 Mn
Dec 31, 2024 -3.96 Mn
Sep 30, 2024 3.55 Mn
Jun 30, 2024 2.88 Mn
Mar 31, 2024 -8.11 Mn
Dec 31, 2023 679,000.00
Sep 30, 2023 5.41 Mn
Jun 30, 2023 -2.41 Mn
Mar 31, 2023 -9.01 Mn
Dec 31, 2022 -248,000.00
Sep 30, 2022 4.93 Mn
Jun 30, 2022 4.78 Mn
Mar 31, 2022 -6.08 Mn
Dec 31, 2021 -2.39 Mn
Sep 30, 2021 6.11 Mn